Quick Heal Technologies Ltd - 539678 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
Call Recording of investor/analyst call held on Thursday, October 20, 202221-10-2022
21-10-2022
Q2FY23 Quarterly Result Announced for Quick Heal Technologies Ltd.
IT software products company Quick Heal Technologies announced Q2FY23 results: Q2FY23: Revenue at Rs 101 crore EBIDTA at Rs 28.4 crore PAT at Rs 22.2 crore H1FY23 Revenue at Rs162 crore EBITDA at Rs 29.4 crore PAT at Rs 22.3 crore Dr. Kailash Katkar, Managing Director and Chief Executive Officer, Quick Heal Technologies Limited, said, “We continue to deliver strong growth in our revenues in the enterprise segment. Q2 marks 9th straight quarter delivering YoY growth for the Enterprise segment. This solidifies our belief in the business we incubated from scratch years ago and has crossed Rs 100 crore revenues in TTM basis. We have taken focussed initiatives and interventions towards our consumer segment which is degrowing at 11% to bring it back to the growth path. We have been investing heavily into our R&D; and S&M; for achieving our vision of growing multifold in the years to come,” he added. Mr. Navin Sharma, Chief Financial Officer, Quick Heal Technologies Limited, said, “The need for cybersecurity is fundamentally increasing owing to the developments happening across the globe. We are overlooking bright opportunities and investing heavily in R&D; and S&M; to address the core and evolving needs of the customers. R&D; investments for the quarter stands at 30% while the S&M; stands at 25%. Our balance sheet remains strong with zero debt and cash and cash equivalents of Rs 338 crore as on 30th September 2022. We are committed to driving shareholder value by growing profitability across both of our segments and driving solid Unlevered Cash Flow and constantly rewarding our shareholders though buyback and dividend distribution programs.” Result PDF20-10-2022
Quick Heal Technologies Ltd - 539678 - Outcome Of The Board Meeting
Pursuant to regulation 30 of the Listing Regulations, we wish to inform you that the Board of Directors of the Company at its meeting held today, i.e. October 19, 2022 which commenced at 5:00 p.m. IST and concluded at 07:25 p.m. IST, inter alia to consider and approve Unaudited Consolidated and Standalone Financial Results of the Company for the quarter and half year ended September 30, 2022.19-10-2022
Quick Heal Technologies Ltd - 539678 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Earnings Call for Q2FY23 Results17-10-2022
Quick Heal Technologies Ltd - 539678 - Board Meeting Intimation for The Un-Audited Financial Results Of The Company (Standalone As Well As Consolidated) For The Quarter And Half Year Ended September 30, 2022
Quick Heal Technologies Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 19/10/2022 ,inter alia, to consider and approve the un-audited Financial Results of the Company (Standalone as well as Consolidated) for the quarter and half year ended September 30, 202217-10-2022
Quick Heal Technologies Ltd - 539678 - Announcement under Regulation 30 (LODR)-Newspaper Publication
We wish to inform that Company has published an offer opening advertisement cum corrigendum to the Public Announcement dated September 30, 2022 ('Advertisement') on October 1, 2022:01-10-2022
Quick Heal Technologies Ltd - 539678 - Closure of Trading Window
Pursuant to the provisions of SEBI (Prohibition of Insider Trading) Regulations, 2015, and the Company''s Code of Conduct to regulate, monitor and report trading by Designated Persons and their Immediate Relatives, the Trading Window for dealing in the securities of the Company shall be closed from October 01, 2022 and shall be opened 48 hours after declaration of Financial Results for the quarter and half year ended on September 30, 2022.30-09-2022
Quick Heal Technologies Ltd - 539678 - Announcement under Regulation 30 (LODR)-Meeting Updates
Submission of Letter of Offer for the Buyback of up to 50,00,000 fully paid-up equity shares of ? 10/- each ('Equity Shares') of Quick Heal Technologies Limited ('Company') at a price of ? 300 per Equity Share for a maximum amount of ? 150 crore ('Buyback Size') through the tender offer process pursuant to the SEBI (Buy Back of Securities) Regulations, 2018, as amended ('Buyback Regulations') (the 'Buyback')26-09-2022
Quick Heal Technologies Ltd - 539678 - Announcement Under Regulation 30 (LODR) Updates- Submission Of Draft Letter Of Offer Pertaining To Proposed Buyback To SEBI.
Submission of draft Letter of offer pertaining to proposed Buyback of equity shares to SEBI.31-08-2022
Quick Heal Technologies Ltd - 539678 - CORRIGENDUM To Our Letter Dated August 29, 2022
In furtherance to our intimation dated August 29, 2022 on the captioned reference, please note that the date of the public announcement for the Buyback and date of announcement of results of e-voting is August 27, 2022 and not August 26, 2022 as was inadvertently mentioned in our intimation dated August 29, 2022.30-08-2022